key: cord-0696396-tbzh0u2v
authors: Bitew, Molalegne; Hailu, Getnet; Gebregziabher Tsegay, Yakob; Tuki, Keyru; Asmamaw, Kominist; Tesfaye, Kassahun; Dadi, Hailu; Orsini, Emanuele; Dal Monego, Simeone; Licastro, Danilo; Marcello, Alessandro
title: SARS-CoV-2 Genome Sequence Obtained from Ethiopia
date: 2022-02-03
journal: Microbiol Resour Announc
DOI: 10.1128/mra.01182-21
sha: 0c2a7f9683568aad112d9b3deea41070e79262f7
doc_id: 696396
cord_uid: tbzh0u2v

The coding-complete severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome sequences from 15 nasopharyngeal swabs collected in Addis Ababa, Ethiopia, during the period from December 2020 to March 2021 were determined using Illumina MiSeq technology. A sequence analysis identified that the B.1 SARS-CoV-2 lineage was most prevalent with the worrying emergence of B.1.1.7 in June 2021.

CA, USA) were used to assess the RNA quantities and qualities, respectively. From the total RNA, 100 ng was processed by the Swift Amplicon SARS-CoV-2 research panel for genome amplification and library preparation (Swift Bioscience, USA). High-throughput sequencing was conducted using an Illumina MiSeq sequencer following the standard protocol for paired-end 150-bp reads. The sequencing and data analysis were done at the ARGO Open Lab Platform for Genome Sequencing of the AREA Science Park and at the International Center for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy. All tools were run with default parameters unless otherwise specified. The raw sequence data were quality controlled using FastQC v0.11.9 (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Genome assembly was conducted using dedicated Swift dockerized data analysis guidelines (7, 8) .

The study was approved by Addis Ababa University, Aklilu Lemma Institute of Pathobiology (ALIP) institutional review board with protocol number ALIPB IRB/52/ 2013/21. Data were collected after permission was obtained from the institute. All the information obtained from the study participants was kept confidential.

For each sample, sequencing parameters (GC content [%], complete length, genome coverage, and number of raw reads) are listed in Table 1 . Briefly, genome length across the samples was 29,817 to 29,878 bp; genome coverage was 18,000Â to 22,000Â for samples S1 to S10 and 3,000Â to 5,000Â for samples S11 to S15.

A phylogenetic analysis was conducted on the 15 sequenced samples using the Nextstrain bioinformatics platform (9, 10) . The coding complete genome sequences were analyzed in the context of the Nextregions/Africa data set, which is available on GISAID (updated to 7 December 2021). An Ethiopia-focused country-level subsampling strategy was performed, using the reference strain "hCoV-19/Wuhan/WH01/2019" (EPI_ISL_402125) as the original root. Results are shown in Fig. 1 . A Nextstrain analysis reveals that SARS-CoV-2 samples from Ethiopia belong to three different Nextstrain clades, as follows: 19B, 20A, and 20I/501Y.V1. A complete description of amino acidic substitutions and linages for each sample is provided in Table 1 .

Data availability. The coding complete genome sequences and metadata of all the 15 samples were submitted to the GISAID database (www.gisaid.org) where they can be accessed through the accession numbers listed in Table 1 . The coding complete genome sequences can be also accessed on the NCBI database (identifiers [IDs] OL840802 to OL840816, see Table 1 ); SRA accessions for each sample are available on the NCBI database under BioProject accession PRJNA780398.

Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China

Epidemiology, genetic recombination, and pathogenesis of coronaviruses

SARS-CoV-2 (COVID-19) by the numbers

WHO Health Emergency Dashboard WHO (COVID-19) Homepage. WHO

Diagnostic performance of colorimetric RT LAMP for the identification of SARS-CoV-2: a multicentre prospective clinical evaluation in sub-Saharan Africa

Isolation and fulllength genome characterization of SARS-CoV-2 from COVID-19 cases in northern Italy

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph

Nextstrain: real-time tracking of pathogen evolution

Genome sequencing of a novel coronavirus SARS-CoV-2 isolate from

We are very grateful for the ICGEB for collaborating in the sequencing activity and funding the transport of 15 RNA samples from Ethiopia. The funding support of Bioinovate Africa is also much appreciated. This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation (grant number INV-022,816). Under the grant conditions of the foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the author accepted manuscript version that might arise from this submission.We are also thankful to the staff of the EBTI COVID-19 diagnostic and research lab for their tremendous effort in detecting and characterizing the samples.